Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voglibose vs Acarbose in T2DM with Poor Metformin Control
NCT02049814Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of voglibose in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Takeda. Primary endpoint: Glycosylated Hemoglobin at 12 weeks. Started May 2014; status: completed.
02
Drugs
voglibose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02049814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049814.